ADAP
Adaptimmune Therapeutics
ADAP
ADAP
85 hedge funds and large institutions have $426M invested in Adaptimmune Therapeutics in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 33 reducing their positions, and 21 closing their positions.
Holders
85
Holders Change
-7
Holders Change %
-7.61%
% of All Funds
1.31%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
15
Increased
17
Reduced
33
Closed
21
Calls
$725K
Puts
$429K
Net Calls
+$296K
Net Calls Change
-$235K